Paper31350853
Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials.
Carrigan G and 8 others. Clin Pharmacol Ther, 2020. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials. Papers, record 31350853. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31350853
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Databases, Factual | Major topic |
| Electronic Health Records | Major topic |
| Lung Neoplasms | Major topic |
| Research Design | Major topic |
| Humans | |
| Proportional Hazards Models | |
| Survival Analysis | |
| United States |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 32542679 | Externally Controlled Trials: Are We There Yet? | https://conductscience.org/library/papers/32542679 |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24465467 | Generation of "virtual" control groups for single arm prostate cancer adjuvant trials. | PLoS One | 2014 | https://conductscience.org/library/papers/24465467 | PubMed |
| 2 | 22207554 | High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients. | Histol Histopathol | 2012 | https://conductscience.org/library/papers/22207554 | PubMed |
| 3 | 30673081 | Modernizing Clinical Trials for Patients With Cancer. | JAMA | 2019 | https://conductscience.org/library/papers/30673081 | PubMed |
| 4 | 27650716 | "Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials? | Clin Pharmacol Ther | 2016 | https://conductscience.org/library/papers/27650716 | PubMed |
| 5 | 28715550 | Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using "Real-World" Data. | JAMA | 2017 | https://conductscience.org/library/papers/28715550 | PubMed |
| 6 | 29756355 | Development and Validation of a High-Quality Composite Real-World Mortality Endpoint. | Health Serv Res | 2018 | https://conductscience.org/library/papers/29756355 | PubMed |
| 7 | 28182270 | Use of External Controls in Regulatory Decision-Making. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28182270 | PubMed |
| 8 | 8957065 | Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/8957065 | PubMed |
| 9 | 29059439 | Real-world Data for Clinical Evidence Generation in Oncology. | J Natl Cancer Inst | 2017 | https://conductscience.org/library/papers/29059439 | PubMed |
| 10 | 19767093 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. | Lancet | 2009 | https://conductscience.org/library/papers/19767093 | PubMed |
| 11 | 19255323 | Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19255323 | PubMed |
| 12 | 27363818 | Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014. | BMJ Open | 2016 | https://conductscience.org/library/papers/27363818 | PubMed |
| 13 | 29881734 | A Data Quality Assessment Guideline for Electronic Health Record Data Reuse. | EGEMS (Wash DC) | 2017 | https://conductscience.org/library/papers/29881734 | PubMed |
| 14 | 27288979 | Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls. | J Thorac Oncol | 2016 | https://conductscience.org/library/papers/27288979 | PubMed |
| 15 | 27096309 | Opportunities and challenges in leveraging electronic health record data in oncology. | Future Oncol | 2016 | https://conductscience.org/library/papers/27096309 | PubMed |
| 16 | 28232724 | Regulatory watch: From big data to smart data: FDA's INFORMED initiative. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/28232724 | PubMed |
| 17 | 29944008 | Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib. | J Comp Eff Res | 2018 | https://conductscience.org/library/papers/29944008 | PubMed |
| 18 | 18506025 | Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18506025 | PubMed |
| 19 | 30873729 | An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database. | Pharmacoepidemiol Drug Saf | 2019 | https://conductscience.org/library/papers/30873729 | PubMed |
| 20 | 21079147 | Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: results of a west Japan oncology group study. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/21079147 | PubMed |
Cited by52
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42704204 | Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/42704204 | PubMed |
| 42415230 | Comparison of epcoritamab, lenalidomide, and rituximab versus usual care in relapsed/refractory follicular lymphoma. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/42415230 | PubMed |
| 42368718 | Testing for treatment effect twice using internal and external controls in clinical trials. | J Causal Inference | 2023 | https://conductscience.org/library/papers/42368718 | PubMed |
| 42277552 | Real-World Evidence of Treatment Patterns, Time to Real-World Progression, and Overall Survival of Patients With Testicular Germ Cell Tumors Receiving Palliative Chemotherapy in the United States. | Cancer Med | 2026 | https://conductscience.org/library/papers/42277552 | PubMed |
| 42164498 | Biomarkers for predicting immunotherapy response and resistance in glioblastoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42164498 | PubMed |
| 41635962 | Sieving for gold: external comparator studies to prioritize drugs for late-stage clinical trial. | J Comp Eff Res | 2026 | https://conductscience.org/library/papers/41635962 | PubMed |
| 40979394 | Application of the target trial emulation framework to external comparator studies. | Front Drug Saf Regul | 2024 | https://conductscience.org/library/papers/40979394 | PubMed |
| 40442865 | Examining the Reliability of Model-Based Meta-Analysis (MBMA) Outcomes: A Simulation Study. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/40442865 | PubMed |
| 40419286 | Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients. | Br J Haematol | 2026 | https://conductscience.org/library/papers/40419286 | PubMed |
| 40377841 | An External Control Arm for the Oral Factor XIa Inhibitor Asundexian Phase 2 Trial in Atrial Fibrillation (PACIFIC-AF) Using Electronic Health Records. | Cardiol Ther | 2025 | https://conductscience.org/library/papers/40377841 | PubMed |
| 40199298 | Clinical Research Informatics: a Decade-in-Review. | Yearb Med Inform | 2024 | https://conductscience.org/library/papers/40199298 | PubMed |
| 40136297 | Quantitative Bias Analysis for Single-Arm Trials With External Control Arms. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40136297 | PubMed |
| 39514601 | A causal inference framework for leveraging external controls in hybrid trials. | Biometrics | 2024 | https://conductscience.org/library/papers/39514601 | PubMed |
| 39487399 | Incorporating external controls in the design of randomized clinical trials: a case study in solid tumors. | BMC Med Res Methodol | 2024 | https://conductscience.org/library/papers/39487399 | PubMed |
| 39285061 | A Framework for the Use and Likelihood of Regulatory Acceptance of Single-Arm Trials. | Ther Innov Regul Sci | 2024 | https://conductscience.org/library/papers/39285061 | PubMed |
| 39102176 | Examining the Effect of Missing Data and Unmeasured Confounding on External Comparator Studies: Case Studies and Simulations. | Drug Saf | 2024 | https://conductscience.org/library/papers/39102176 | PubMed |
| 39073872 | Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. | JMIR AI | 2024 | https://conductscience.org/library/papers/39073872 | PubMed |
| 38984669 | Examining external control arms in oncology: A scoping review of applications to date. | Cancer Med | 2024 | https://conductscience.org/library/papers/38984669 | PubMed |
| 38965433 | Harnessing EHR data for health research. | Nat Med | 2024 | https://conductscience.org/library/papers/38965433 | PubMed |
| 38785683 | Comparing prospectively assigned trial and real-world lung cancer patients. | J Comp Eff Res | 2024 | https://conductscience.org/library/papers/38785683 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| HGF | 3082 | PubTator's text mining | https://conductscience.org/library/genes/3082 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31350853
GET https://conductscience.org/api/papers/v1/31350853/references?page=2